Mirafuentes, Den Marc K.

HRN: 21-23-92  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2025
CEFUROXIME 750MG (VIAL)
05/29/2025
06/04/2025
IV
566
Q8
Uti
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: